Positive benefits of a pharmacist-managed hypertension clinic in Nigeria

Public Health

Volumn 119, Issue 9, 2005, Pages 792-798

  Erhun, W O ^a   Agbani, E O ^b   Bolaji, E E ^c  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b NIGER DELTA UNIVERSITY   (Nigeria)

^c Comprehensive Health Centre ^*  (Nigeria)

Author keywords

Clinical outcome; Combination diuretic; Hypertension; Nigeria; Pharmacist

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; METHYLDOPA;

DRUG PRESCRIBING; HYPERTENSION;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE RESISTANCE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NIGERIA; OUTPATIENT; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACEUTICAL CARE; PHARMACIST; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT REDUCTION;

AGED; AMILORIDE; ANTIHYPERTENSIVE AGENTS; COMMUNITY HEALTH CENTERS; COUNSELING; DIURETICS; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; METHYLDOPA; MIDDLE AGED; NIGERIA; PATIENT EDUCATION; PHARMACISTS; PROGRAM EVALUATION; TREATMENT OUTCOME;

AFRICA; EASTERN HEMISPHERE; NIGERIA; SUB-SAHARAN AFRICA; WEST AFRICA; WORLD;

EID: 22544462791     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2004.11.009     Document Type: Article

References (27)

1. R. Collins R. Peto S. MacMahon P. Hebert N.H. Fiebach K.A. Eberlein J. Godwin N. Qizilbash J.O. Taylor C.H. Hennekens Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomised drug trials in epidemiological context Lancet 335 1990 827-838
2. L.E. Ramsay B. Williams G.D. Johnston G.A. MacGregor L. Poston J.F. Potter N.R. Poulter G. Russell British hypertension society guidelines for hypertension management: Summary BMJ 319 1999 630-635
3. Department of Health Health Survey for England 1998 Department of Health London
4. Scottish Health Statistics 2000. Web resource. Edinburgh. http://www.show.scot.nhs.uk/isd/scotish_health_statistics/SHS2000/ home.htm
5. D.A. Sclar Disease state management: An overview for the managed care pharmacist Drug Benefit Trends 7 1996 10-11
6. W.O. Erhun E.O. Agbani E.E. Bolaji Managing hypertension with combination diuretics and methyldopa in Nigerian blacks at the primary care level Clin Drug Invest 23 2003 583-590
7. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-2446
8. National Heart Lung and Blood Institute (NHLBI) obesity education imitative: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report, NIH Publication No. 98-4083, National Institutes of Health; 1998
9. MRC Working Party Medical Research Council trial of treatment of hypertension in older adults: Principal results BMJ 304 1992 405-441
10. A.L. Klatsky G.D. Friedman A.B. Siegelaub M.J. Gerard Alcohol consumption and blood pressure N Engl J Med 296 1977 1194
11. M.P. Okamoto R.K. Nakahiro Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic Pharmacotherapy 21 2001 1337-1344
12. J.M. McKenney J.M. Slining H.R. Henderson D. Devins M. Barr The effect of clinical pharmacy services on patients with essential hypertension Circulation 48 1973 1104-1111
13. P.J. Schneider J.N. Larrimer J.A. Visconti W.A. Miller Role effectiveness of a pharmacist in the maintenance of patients with hypertension and congestive heart failure Contemp Pharm Pract 5 1982 74-79
14. B.L. Carter D.J. Barnette E. Chrischilles G.J. Mazzotti Z.J. Asali Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting Pharmacotherapy 17 1997 1274-1285
15. T.P. Reinders D.R. Rush R.P. Baumgartner Jr A.W. Graham Pharmacist's role in management of hypertensive patients in an ambulatory care clinic Am J Hosp Pharm 32 1975 590-594
16. Afolabi MO, Erhun WO. Patients response to waiting time in an outpatients pharmacy in Nigeria. Trop J Pharm Res; Dec. 2003;2(2):207-214.
17. L.Y. Kiyohara L.K. Kayano K.L. Kobayashi M.S. Alessi M.U. Yamamoto P.R. Yunes-Filho R.R. Pessoa R. Mandelbaum S.T. Okubo T. Watanuki J.E. Vieira The patient-physician interactions as seen by undergraduate medical students Sao Paulo Med 119 2001 97-100
18. Spencer C, Lip G. Management of the hypertensive patient. Pharm J; Sept. 1999;263:383-386
19. A.G. Shaper G. Wannamethee M. Walker Physical activity hypertension and risk of heart attack in men without evidence of ischaemic heart disease J Hum Hypertens 8 1994 3
20. J. Staessen R. Faggard P. Linjen A. Amery Body weight, sodium intake and blood pressure Ibid 7 Suppl. 1 1989 19
21. J.F. Setaro H.R. Black Refractory hypertension N Engl J Med 327 1992 543-547
22. N.H. Miller M. Hill T. Kottke I.S. Ockene The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals, AHA special report Circulation 95 1997 1085-1090
23. A. Hampton A. Wilson M. Hussain Measuring blood pressure in an inner city pharmacy: An attempt at coordination with general practice Fam Pract 7 1990 52-55
24. Giberson S, Cox T. Indian Health Service: Leader in Pharmaceutical Services. www.hhs.gov/pharmacy/pdf/giberson.pdf
25. F.G. Paavola K.R. Dermanoski R.E. Pittman Pharmaceutical service in the United States Public Health Service Am J Health Syst Pharm 54 1997 766-772
26. R.M. Church K.R. Dermanoski T.B. Pukas Pharmacy practice roles in the US Public Health Service: A portrait of diversity J Pharm Pract 3 1990 389-397
27. K. Flobbe C.B. IJsselmuiden P. Rheeder J.J. Gerber M. Lubbe The pharmacy screening project - an evaluation of pharmacy-based screening programmes S Afr Med J 89 1999 980-986